Phenanthriplatin(iv) conjugated multifunctional up-converting nanoparticles for drug delivery and biomedical imaging
- 13 July 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 6 (31) , 5059-5068
Abstract
Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used in the clinical treatment of cancer. However, the clinical applications of platinum-based drugs are greatly limited by the side-effects, lack of selectivity, fast blood clearance, and intrinsic or acquired drug resistance. In this study, we report an anticancer drug delivery system based on phenanthriplatin(IV) (Phen-Pt(IV))-conjugated NaGdF4:Yb3+/Er3+ nanoparticles. The upconversion luminescent NaGdF4:Yb3+/Er3+ nanoparticles (UCNPs) were further modified with polyethyleneimine (PEI), poly(ethylene glycol) (PEG) and the cancer targeting ligand arginine–glycine–aspartic peptide (RGD), resulting in the formation of water-dispersible and biologically functionalized UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles. The Phen-Pt-conjugated UCNP@PEI–Phen-Pt–PEG–RGD nanoparticles exhibited an obvious cytotoxic effect on Hep-2 cells (Human Laryngeal Carcinoma cell line) via MTT assay. Meanwhile, the endocytosis process of Phen-Pt-conjugated NaGdF4:Yb3+/Er3+ nanoparticles by Hep-2 cells was demonstrated through flow cytometry and ICP-MS. In addition, the upconversion luminescence image of UCNP@PEI–Phen-Pt–PEG–RGD taken up by cells shows green emission under 980 nm infrared laser excitation, making the UCNP@PEI–Phen-Pt–PEG–RGD nanocomposites promising candidates as bioimaging agents. Moreover, these UCNPs were further explored for in vitro and in vivo T1-weighted magnetic resonance (MR) imaging. The in vivo experiments on mice also confirmed that the Phen-Pt(IV)-conjugated nanoparticles have a relatively high tumor inhibition rate. These results indicate that the multifunctional nanoparticles can be expected to be a platform for simultaneous imaging and cancer therapeutic applications.Keywords
Funding Information
- National Natural Science Foundation of China (51772124, 51720105015, 51672269, 51332008, 21728101, 21521092)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2017273)
- Chinese Academy of Sciences (YZDY-SSW-JSC018)
This publication has 54 references indexed in Scilit:
- A novel probe for the non-invasive detection of tumor-associated inflammationOncoImmunology, 2013
- Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profileProceedings of the National Academy of Sciences, 2012
- Self-Assembled β-NaGdF4 Microcrystals: Hydrothermal Synthesis, Morphology Evolution, and Luminescence PropertiesInorganic Chemistry, 2011
- Structure of duplex DNA containing the cisplatin 1,2-{Pt(NH3)2}2+-d(GpG) cross-link at 1.77Å resolutionJournal of Inorganic Biochemistry, 2010
- Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in AnimalsSmall, 2010
- X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adductProceedings of the National Academy of Sciences, 2010
- Inhibition of transcription by platinum antitumor compoundsMetallomics, 2009
- cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospectsProceedings of the National Academy of Sciences, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007